This inventor holds 1 USPTO granted patent and 2 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignee: Mesoblast International Sarl. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Fiona See - Innovator in Mesenchymal Stem Cell Research
Introduction
Fiona See is an accomplished inventor based in the United States. She has made significant contributions to the field of stem cell research, particularly in the area of mesenchymal lineage precursor cells. Her innovative work focuses on the therapeutic efficacy of these cells, which has the potential to impact regenerative medicine.
Latest Patents
Fiona See holds a patent titled "Potency Assay." This invention relates to a method for determining the biological activity or therapeutic efficacy of cultured mesenchymal lineage precursor cells or stem cells based on their released TGF-9 levels in culture. The patent also discusses isolated populations of these cells selected based on their TGF-9 levels. Furthermore, it outlines a treatment method for subjects suffering from degenerative disc disease by administering the selected cell populations.
Career Highlights
Throughout her career, Fiona has focused on advancing the understanding of stem cell biology. Her research has contributed to the development of new therapeutic strategies for degenerative diseases. Despite having 1 patents, her work remains influential in the scientific community.
Collaborations
Fiona has collaborated with notable colleagues, including Paul Simmons and Colby Suire. These partnerships have enhanced her research and expanded the impact of her findings in the field of regenerative medicine.
Conclusion
Fiona See is a dedicated inventor whose work in mesenchymal stem cell research holds promise for future therapeutic applications. Her innovative approaches continue to inspire advancements in regenerative medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile